+91 9860854331
sales@mdatapartners.com

Drug Data

Hemophilia A Drug Total Revenue (Rare Disease) - Global - Novo Nordisk

(in million Danish Krone)

Description

Novo Nordisk Company is a global biopharmaceutical company.

  • Last Updated Date : 28 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Novo Nordisk (ANNUAL REPORT FORM 10-K)
  • Competitors : Roche
Hemophilia A Drug Total Revenue (Rare Disease) - Global - Roche

(in million Swiss Franc)

Description

Roche Company is a global biopharmaceutical company.

  • Last Updated Date : 28 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Roche (ANNUAL REPORT FORM 10-K)
  • Competitors : Novo Nordisk
Hemophilia A Drug Total Revenue (Rare Disease) - Global - Bayer

(in million Euro)

Description

Bayer Company is a global biopharmaceutical company.

  • Last Updated Date : 28 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Bayer (ANNUAL REPORT FORM 10-K)
  • Competitors : Sanofi
Hemophilia A Drug Total Revenue (Rare Disease) - Global - Sanofi

(in million Euro)

Description

Sanofi Company is a global biopharmaceutical company.

  • Last Updated Date : 28 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Sanofi (ANNUAL REPORT FORM 10-K)
  • Competitors : Bayer
Hemophilia Drug Total Revenue (Rare Disease) - Global - Pfizer

(in million U.S. dollars)

Description

Pfizer Company is a global biopharmaceutical company.

  • Last Updated Date : 28 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : Pfizer (ANNUAL REPORT FORM 10-K)
  • Competitors : Sanofi

Other Statistical Reports

Immunology

Oncology

Cardiology

Dermatology And Aesthetics

Infectious Diseases And Vaccines

Neuroscience

Ophthalmology

Respirology

Metabolism

Other Internal Medicine

Have questions about how our healthcare intelligence solutions can empower your organization?

Contact Us
up